Articles tagged with Cancer Treatments
Researchers have developed an AI algorithm that can track protein clumping under the microscope in real-time, revolutionizing the study of neurodegenerative disorders. The tool helps identify key characteristics of clumped proteins, which can lead to new therapies.
A study analyzed serum bile acid profiles in patients with colonic polyps and cancer, finding lower deoxycholic acid levels and higher taurocholic acid levels in those with colonic neoplasms. The study suggests a potential relationship between bile acid profiles and colonic neoplasms risk.
Researchers found that miR-377 reduces MYC mRNA levels, leading to increased Bax and PTEN expression and decreased CDK4. This results in induced apoptosis, inhibited proliferation, and arrested cell cycle in prostate cancer cells.
A cross-sectional study reveals racial and ethnic disparities in treatment delays and discontinuations among patients with SARS-CoV-2, leading to increased cancer mortality among minoritized adults. The disproportionate burden varied across SARS-CoV-2 waves.
A team of researchers developed a hybrid nanotube stamp system for intracellular protein delivery, achieving high efficiency and cell viability rates in cancer treatment. The system successfully delivered therapeutic proteins into target cells with precision, showing promising efficacy and safety.
Researchers found no significant improvement in overall survival after systemic therapy for patients with very advanced solid tumors. The study highlights the importance of providers focusing on palliative and supportive care options that have been demonstrated to improve quality of life and survival.
Human umbilical cord mesenchymal stem cells (hUC-MSCs) have been shown to alleviate acute liver failure by inhibiting hepatocyte apoptosis and regulating macrophage polarization. This study suggests that hUC-MSC-based cell therapy may serve as an alternative option for patients with liver failure.
A plant virus treatment, composed of cowpea mosaic virus nanoparticles, has shown remarkable success in improving survival rates and suppressing the growth of metastatic tumors across various cancer models. The treatment was effective even after surgical removal of tumors, indicating its potential to prevent metastasis.
Researchers have developed a new method to study slow electrons in solids, allowing for the deciphering of previously inaccessible information. By combining data from fast and slow electrons, scientists can now investigate how electrons release energy in their interaction with materials, crucial for applications such as cancer therapy ...
Researchers have developed a new method to detect malignant melanoma using a microneedle patch that measures tyrosinase enzyme levels in the skin. This non-invasive technique has the potential to provide faster and more reliable results compared to traditional biopsies.
A cross-sectional study found racial and ethnic disparities in breast cancer treatment declination and overall survival. The study suggests that patient education on treatment benefits and improved communication between patients and clinicians can help reduce disparities and improve patient outcomes.
Researchers developed a Pix-2-Pix GAN model to correct PSMA PET/CT images, improving image quality and quantitative markers. The AI-generated images show high correlation with original images and potential for reducing CT scans without compromising image quality.
A massive study identifies new biomarkers for renal cell carcinoma subtypes, improving diagnosis and treatment. The researchers' integrative analysis of proteogenomic datasets reveals molecular features shared by clear cell and non-clear cell RCC tumors, as well as unique features to various subtypes.
The summit aimed to improve care for people with cancer by discussing knowledge gaps, societal stigma, and shifting policies. Experts emphasized the importance of education about sexual and reproductive health in cancer treatment.
The prevalence of lung cancer mutations varies significantly across different ethnic groups in Latin America, highlighting the need for region-specific medical interventions. Enhancing molecular diagnostic and research efforts is crucial for effective management of cancer in this population.
A new AI model developed by researchers at the University of British Columbia can accurately predict if a patient receiving cancer care will require mental health services. The AI analyzes oncologist's notes and identifies subtle clues that suggest a patient may benefit from early psychiatric or counselling interventions.
A new study suggests that proteins detectable in the blood could improve predictions about risk of liver cancer, potentially leading to earlier therapeutic interventions. The researchers used proteomics to develop a prediction model and identified 56 plasma proteins associated with liver cancer.
A new set of clinical practice standards and recommendations offers tailored and effective care for individuals with advanced and metastatic cancer. The initiative, backed by MASCC and ASCO, provides a critical resource to healthcare stakeholders.
A randomized clinical trial of 3,020 patients with high-risk nonmetastatic breast cancer found daily aspirin therapy had no effect on breast cancer recurrence or survival in early follow-up. Aspirin should not be recommended as an adjuvant breast cancer treatment despite its potential benefits and wide availability
Researchers at the University of Leipzig Medical Center have identified biomarkers associated with the response to CAR T cell therapy in multiple myeloma. These biomarkers enable patients to predict their likelihood of responding well or less well to treatment before initiating therapy.
A study from Medical University of Vienna reveals a new molecular signaling pathway crucial to liver cancer development, offering potential new therapeutic targets. The research also identifies the c-Jun/Fra-2 complex as essential in triggering tumour growth.
Women with germline BRCA pathogenic variants face increased risk of mortality from postpartum breast cancer, particularly those diagnosed under 10 years after giving birth. The study highlights the importance of genetic counseling and tailored prevention strategies for these high-risk individuals.
A new AI-based approach, PERCEPTION, uses single-cell transcriptomics to predict patient response to cancer drugs and monitor resistance. The approach was validated in three clinical trials for multiple myeloma, breast, and lung cancer, with promising results.
A national cohort study found that neighborhood disadvantage was independently associated with shorter breast cancer–specific survival. The study suggests potential unaccounted-for mechanisms, including both nonbiologic and biologic factors, and highlights the need for further research.
Only 4% of cancer survivors met all four American Cancer Society guidelines, with a mean of 2.0 guidelines met. This study aims to improve understanding of guideline adherence and inform recommendations for patients who have completed cancer treatments.
The authors suggest a regulatory approach that accommodates the unique characteristics of generalist AI models while ensuring patient safety and supporting physician decision-making. This is crucial as rigid frameworks may hinder progress in AI-driven healthcare, while hybrid approaches could be viable solutions.
Researchers from Osaka University have discovered a way to deliver antisense oligonucleotides to their targets inside cancer cells by opening specific calcium permeable channels. The new compound, L687, promotes efficient uptake of ASO into cancer cells, suppressing target gene activity and enhancing ASO efficacy.
Researchers at Tampere University and Hospital discovered that aberrant DNA methylation contributes to the development of aggressive AT/RT brain tumors in young children. This finding paves the way for a deeper understanding of the disease and potential new treatments.
Young breast cancer survivors without germline pathogenic variants are at lower risk for developing a second primary breast cancer within the first decade after diagnosis. This study informs treatment decision-making and follow-up care considerations in this population.
This study evaluated somatic copy number alterations (SCNAs) and mutation landscapes in malignant rhabdoid tumors before and after treatment. The results revealed recurrent SCNAs harboring genes involved in tumorigenesis, with some correlations between gene expression and tumor progression.
Researchers at Tokyo Medical and Dental University have developed a novel method for coating engineered messenger RNA molecules with polyethylene glycol (PEG), allowing selective delivery to the spleen. This breakthrough enables fine-tuned control over mRNA therapy, facilitating effective treatment of diseases previously considered inc...
New findings in The American Journal of Pathology indicate that periostin promotes esophageal squamous cell carcinoma progression by enhancing cancer and stromal cell migration in cancer-associated fibroblasts. Periostin may be a promising therapeutic target for treating ESCC.
The study assessed relationships between TCM syndromes and lung cancer TNM staging indicators, finding phlegm dampness syndrome dominant in stages I & II, Qi Yin deficiency syndrome in stages III & IV. The findings suggest bias in included literature, emphasizing the need for larger sample sizes and clinical experimental investigations.
Researchers have identified specific gut microbiota signatures associated with KRAS mutations in colorectal cancer. The study suggests that these microbes may serve as non-invasive biomarkers for identifying subtypes of CRC and inform personalized treatment approaches.
Researchers used single-molecule microscopy and X-ray crystallography to discover that pathogenic JAK2 mutations utilize pseudokinase domain-mediated dimerization as a mechanism for activation. The study provides new insights into the molecular basis of JAK2 activation and its role in blood cancers.
A new study from the University of Miami Miller School of Medicine shows that community-based screening and treatment for Helicobacter pylori bacterium infection can identify and eliminate high-risk individuals. The approach aims to prevent gastric cancer in vulnerable populations, including Blacks, Asians, and Latinos.
Researchers at Mass General Cancer Center presented advancements in rapid nucleic acid detection for cervical cancer screening using CRISPR technology. They also showcased improvements to CAR T cell therapy for pancreatic cancer, highlighting the importance of dynamic functional control to enhance its efficacy.
A Northwestern University study found ChatGPT's responses to radiation oncology patient questions were on par or exceeded professional society answers. The AI technology aims to empower patients before and after seeing physicians, while also reducing clinician burnout.
A 10-center study found that microwave ablation is associated with similar progression-free survival rates to surgery but with fewer complications and a greater potential for preserving thyroid function. The procedure resulted in less blood loss, shorter incision length, and shorter procedure and hospitalization durations.
Researchers found that doctors can confidently skip 50% of biopsies by combining MRI-based prostate imaging reporting and data system scores with prostate-specific antigen density testing. The study suggests that this approach can decrease patient harm and healthcare costs associated with unnecessary biopsies.
A survey of 204 oncologists found that while patients should understand AI models, most agreed that patients should consent to their use. The study highlights the need for rigorous assessments of AI's impact on care decisions and patient autonomy.
A study published in the Journal of the American College of Surgeons found that hospitals accredited by the National Accreditation Program for Rectal Cancer (NAPRC) demonstrate significantly better outcomes for patients undergoing rectal cancer surgery. These institutions show lower rates of mortality, complications, and morbidity comp...
A study published in Nature Genetics reveals early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations, suggesting a potential target for breast cancer prevention. The researchers created the world's largest catalogue of human breast cells, which may lead to the use of existing immunotherapy drugs as an early intervention.
Researchers unveil innovative strategies to overcome metabolic constraints in CAR-T cell therapy, aiming to boost its efficacy in treating solid tumors. Metabolic interventions targeting immunosuppressive metabolites, metabolite uptake, and mitochondrial metabolism are proposed to enhance anti-tumor activity.
A study published in International Journal of Cancer found that men with advanced degrees and higher incomes are more likely to receive comprehensive care for prostate cancer, including MRI scans and curative treatment. This leads to lower mortality rates from the disease compared to those with lower education and income.
Researchers developed a real-time temperature reconstruction technique for HIFU treatment, enabling accurate monitoring and planning. This approach uses deep learning to transform ultrasonic images into temperature images in just a few milliseconds.
Researchers have identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery and reducing bacterial burden in tuberculosis-infected rabbits. The study leverages decades of cancer research to study tuberculosis-affected lung tissue and improves treatment.
Researchers found no significant differences between standard and keyhole surgical incision types on short-term clinical outcomes, physical function recovery, or NHS resource costs for oesophageal cancer patients. The ROMIO study suggests that surgeons can maintain their preferred procedure type without compromising patient care.
Research reveals a significant connection between oral bacteria and accelerated pancreatic cancer development in mice. Viable Porphyromonas gingivalis was found in the pancreas of healthy mice after gum application, causing changes in the organ's microbial balance.
Researchers have discovered a new immunotherapy approach to overcome resistant leukemia by targeting the mutated TP53 gene. Combining pharmacological therapies with genetically engineered CAR T-cells increases effectiveness against cancer cells, offering promising strategies for patients with resistant disease.
Researchers have developed a new tool to help clinics recruit patients from more communities by analyzing nearby hospitals serving diverse populations. The approach aims to increase accessibility and diversity in cancer trials, with the potential to improve patient outcomes.
NeXT Personal assay detects up to ~1,800 somatic variants specific to the patient's tumor with a detection threshold of 1.67 PPM and 99.9% specificity. The assay showed linearity over a range of 0.8 to 300,000 PPM.
A combined PET-MRI scan improved treatment outcomes for 57 out of 205 patients with early-stage breast cancer. The scan helped doctors spot signs of tumour spread, enabling alternative treatments such as chemotherapy or different surgical approaches.
A UNIGE team has identified the mechanism of action of PARP inhibitors, used to treat breast and ovarian cancer. By blocking one activity while preserving another, these inhibitors can maintain toxic effects on cancer cells while sparing healthy cells.
Researchers found that young breast cancer patients who received a low-dose radiotherapy boost had a lower risk of local recurrence after 10 years, with only 4.4% experiencing recurrence. In contrast, high-dose boosts resulted in fewer recurrences but also more severe fibrosis and cosmetic issues.
A study by IRB Barcelona and Sant Joan de Déu Hospital reveals three distinct patterns explaining the occurrence of second cancers in children, including a mutational footprint from chemotherapy. The research advances understanding of pediatric cancer and highlights the importance of clinical data sharing.
A new study suggests that magnetic resonance imaging (MRI) and lumbar puncture may not be necessary for diagnosing and managing immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR T-cell therapy recipients. EEG findings often led to adjustments in medications, indicating its continued importance as a diagnostic tool.
Researchers have demonstrated that attaching 'empty' backpacks to neutrophils activates them against cancer. The treated neutrophils infused into mice with cancer activated other immune cells and reduced tumor size. This technique is attractive as a 'drug-free' cell therapy for cancer.
Researchers have developed diverse nanoparticles for cancer therapy, including micelles, liposomes, and hybrid nanoparticles, which can overcome challenges and deliver drugs with enhanced targeting abilities.
A meta-analysis of mitochondria-related gene expression data reveals an imbalance in mitochondrial functions after trastuzumab treatment, potentially leading to heart failure. The study provides innovative insights into the mechanisms of trastuzumab cardiotoxicity and informs future drug discovery and precision oncology research.